All visitors must wear a face mask covering the nose and mouth, regardless of vaccination status. Learn More » | Walk-in COVID-19 vaccines are available this week. View Times »

Beaumont doctor receives first dose of COVID-19 vaccine
Call to Schedule
Not an active myBeaumontChart user? Call to schedule your appointment today.
Walk-In Hours
Beaumont is now offering walk-in COVID-19 vaccinations for people age 12 and up.
View Hours
View Hours

COVID-19 Vaccine Frequently Asked Questions

Getting the Vaccine

All people age 12 and up are now eligible to received the COVID-19 vaccine at Beaumont. To schedule, call 800-592-4784 or view our walk-in hours.

All people age 12 and up are now eligible to eligible to receive the COVID-19 vaccine at Beaumont. To schedule, call 800-592-4784 or view our walk-in hours.

Beaumont is offering walk-in hours at all three clinics. View our walk-in hours.

It is recommended that you wait at least 90 days from symptom onset to schedule your appointment.

There are very few individuals who cannot receive the COVID-19 vaccine. If in doubt, rather than withholding vaccination, seek advice from your primary care physician, relevant specialist or immunization team right away. Beaumont will follow guidance issued by the CDC and FDA to identify individuals who should not receive the vaccine.

Minor illnesses without fever or systemic upset are not valid reasons to postpone immunization. People currently sick and experiencing COVID-19 symptoms should not receive the vaccination until they recover.

All approved vaccines appear to be equally effective across all racial and ethnic groups based on the research studies.

Currently, the CDC recommends waiting 14 days between vaccinations for other illnesses.

There is insufficient data to support a need to delay surgery after immunization; however, given the potential side effects from the vaccine, waiting a few days is reasonable. Since it takes approximately two weeks after the second dose to allow immunity to fully develop against COVID-19, waiting that period of time for elective surgeries is also reasonable. Urgent or emergent surgeries should not be delayed because of the vaccine.

There is a card that will be given to people who receive the vaccine and they need to bring that with them to the second visit as well. It includes which vaccine they were administered, along with the date and lot number.

If needed, you will be scheduled for your second dose appointment during your first vaccine visit. If you need to reschedule your appointment, view our step-by-step instructions.

Depending on the type of vaccine you get, three to four weeks is the typical amount of time between the two doses. However, the Centers for Disease Control and Prevention says the vaccine remains effective when patients receive the second dose up to 6 weeks after the first dose.

The number and type of vaccine Beaumont receives vary week to week, depending on what the State of Michigan sends us. Therefore, you are not able to select the type of vaccine you receive when scheduling.

No. Once you receive the first dose of a vaccine, you will be scheduled to receive the same type of vaccine for your second dose. Although both vaccines are equally effective in preventing COVID-19, the timing between the first and second doses are different, and they have different ingredients.

  • While Beaumont, like other vaccine providers, will charge your insurance an administration fee, the COVID-19 vaccine is free to you.
  • Beaumont will NOT bill you for patient due balances for this vaccine visit that are not covered by your insurance company.
  • Beaumont will not bill you if you do not have insurance coverage.
  • You may receive an Explanation of Benefits (EOB) from your insurance company. If you receive an EOB statement, you can disregard any references to you potentially paying out of pocket for the vaccine.
  • If you have any questions, please call Beaumont customer service at 248-577-9205

Safety, Side Effects and Effectiveness

The most common side effects that have been reported with the COVID-19 vaccine include:

  • Injection site pain
  • Tiredness
  • Headache
  • Muscle pain
  • Chills
  • Joint pain
  • Fever
  • Injection site swelling
  • Injection site redness
  • Nausea
  • Feeling unwell
  • Swollen lymph nodes

There is a remote chance that the vaccine could cause a severe allergic reaction. This will typically occur shortly after receiving a dose of the vaccine. Signs of a severe allergic reaction include:

  • Difficulty breathing
  • Swelling of your face and throat
  • A fast heartbeat
  • A bad rash all over your body
  • Dizziness or weakness

This vaccine is still being studied in clinical trials. Serious and unexpected side effects may occur.

Our vaccination clinic has a private area staffed with doctors and nurses to assess and treat any adverse reactions that may occur.

Based on the study data, some individuals may have somewhat increased symptoms with the second dose compared with the first. These symptoms should still be manageable with simple over-the-counter interventions such as ibuprofen.

We are fortunate that recent advances over the past few years allowed this technology to be immediately utilized to rapidly develop COVID-19 vaccines with very promising efficacy results without compromising safety. For example, the lipid nanoparticle (LNP) carrier, essential for efficient delivery of the mRNA, were FDA approved only a couple years ago. Additional vaccines for rabies, Zika and influenza remain under development and it is likely we will see other mRNA vaccines approved in the near future.

CDC is recommending even those who have had COVID-19 and have antibodies receive the vaccine, so this is not a problem. However, we ask you wait 90 days after the first onset of symptoms to schedule your first vaccination.

The Society for Maternal-Fetal Medicine strongly recommends vaccination and inclusion in vaccine trials, and as the leading professional society focused on pregnancy, this is a course we strongly support.

Despite the stated commitment of the Department of Health and Human Services, NIH and CDC to prioritize the inclusion of pregnant and lactating women in in SARS-CoV-2 vaccination trials, review of the clinical trials registry indicate pregnant women are being systematically excluded from vaccine Phase III trials. Vaccine research data is currently, therefore, absent for pregnancy and lactation.

Make sure to discuss this with your OB-GYN if you have pregnancy or reproductive concerns. And remember, you are at risk for contracting COVID-19, just like everyone else, so please adhere to the measures that are known to work such as social distancing, wearing a mask and frequent hand washing.

Despite the absence of research data, vaccination is strongly recommended in pregnancy. This is because pregnant women in general appear to be at higher risk of complications if they contract COVID-19 than the general population.

The benefits of COVID-19 vaccination appear to greatly exceed the theoretical risks, so our professional societies are recommending vaccination. Women of childbearing age are over-represented, compared to other fields, in the health care industry. A high percentage of pregnancies are unplanned, so getting the vaccination will reduce your risk of getting COVID-19 and suffering severe complications if you do become pregnant.

Regarding vaccine safety, the Pfizer/BioNTECH and Moderna vaccines use mRNA, which makes a protein fragment that induces immunity in the vaccinated individual. So, the risk to the fetus and pregnancy is thought to be low, compared to using an intact, replicating virus for the vaccination.

There is no evidence regarding the effect of vaccine on reproductive health. Other vaccinations against respiratory viral infections, such as influenza, do not suggest a negative effect on reproductive health from vaccination.

There was an initial concern that getting COVID-19 increases the risk of miscarriage, however, subsequent evidence does not appear to support this.

Beaumont Health has established a vaccine review subcommittee comprised of experts in Infection Prevention, Research, Nursing and Pharmacy that will review all available data and make a recommendation to the Vaccine Steering Committee about proceeding to offer vaccine to employees, physicians and the community. Beaumont is committed to ensuring any vaccine provided to a Beaumont employee is deemed safe by our expert panel.

Thanks to new information, Beaumont re-vamped the process for determining who can safely be vaccinated at one of our vaccine clinics, and who should receive the vaccine at an alternate site.

  • If you have ever had a severe reaction to the COVID-19 vaccines, or any of their components, you cannot receive the vaccine.
  • If you have had an anaphylactic reaction to any vaccine or injectable, you cannot receive the COVID-19 vaccine at Beaumont at this time without an approval/evaluation from an allergist. However, you can be evaluated by an allergist or immunologist to see if you can safely receive the vaccine at an alternate clinic. The vaccine appointment may be scheduled after your allergist approves if you meet the state’s distribution criteria. Please bring your allergist’s written approval to the vaccine appointment.
  • If you have had any other kind of anaphylactic reaction, such as to food or the environment, you can receive the vaccine at one of our vaccine clinics if you meet the state’s distribution criteria. However, you will be asked to remain in observation for 30 minutes instead of 15 minutes.

There is a very low risk of having a severe reaction to any of the vaccines, and there shouldn't be a preference for one over the other due to allergies. According to the CDC, most of all severe allergic reactions occur within 15 minutes of vaccination, which is when patients are in the observation area of the vaccine clinics. Allergic reactions to food or environmental causes are not a factor in getting vaccinated for COVID-19.

After Vaccination

The CDC recently issued guidelines on how fully vaccinated people can visit safely with others. Someone is considered fully vaccinated two weeks after their final dose of the vaccine.

We don’t yet know how long the protection from the vaccine will last. Once more data is available, we will be able to determine how frequently we will need booster vaccine doses.

Protection begins building soon after the first dose, and studies suggest maximum protection begins about 7 to 14 days after the second dose.

The CDC recently issued guidelines for fully vaccinated people. Someone is considered fully vaccinated two weeks after their final dose of the vaccine. Please continue to follow federal, state, local, tribal, or territorial laws, rules, and regulations, including local business and workplace guidance.

About the COVID-19 Vaccines

The mRNA vaccines from Pfizer and Moderna are a new type of vaccine to protect against infectious diseases. To trigger an immune response, many vaccines put a weakened or inactivated germ into our bodies. Not mRNA vaccines. Instead, they teach our cells how to make a protein — or even just a piece of a protein — that triggers an immune response inside our bodies. That immune response, which produces antibodies, is what protects us from getting infected if the real COVID-19 virus enters our bodies.

Not all manufacturers are creating mRNA vaccines.

During early studies, researchers found that the Pfizer and Moderna vaccines provoke a relatively weak immune response when given as just one dose. There was a stronger immune response when a second dose was added. Basically, the first dose of the vaccine starts the process of building up protection. The second dose works to greatly reinforce this protection. It is not uncommon for vaccines to require more than one dose.

Depending on the type of vaccine you receive, the CDC recommends the two doses be given 3 or 4 weeks apart. However, the second dose can be given up to six weeks later.

All the approved vaccines are preservative free and do not contain Thimerosal.

Three COVID-19 vaccines have been given emergency use authorization by the FDA in the United States.

Compare all available COVID-19 vaccines